Biomarker snapshots - neurological and psychiatric disorders
The identification of novel biomarkers is a crucial step in advancing towards earlier detection of diseases, as well as more personalized treatment options. This snapshot summarizes some of the biochemical and genomic biomarkers reported recently in the literature and at leading industry conferences in the field of neurological and psychiatric disorders..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:043 |
|---|---|
| Enthalten in: |
Drugs of the future - 043(2018), 3, Seite 0193 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bofill,US!aX. [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| doi: |
10.1358/dof.2018.043.03.2792546 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2000499988 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2000499988 | ||
| 003 | DE-627 | ||
| 005 | 20230516073303.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180809s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1358/dof.2018.043.03.2792546 |2 doi | |
| 028 | 5 | 2 | |a fidpha__2018-08-09.pp |
| 035 | |a (DE-627)OLC2000499988 | ||
| 035 | |a (DE-599)GBVOLC2000499988 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Bofill,US!aX. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biomarker snapshots - neurological and psychiatric disorders |
| 264 | 1 | |c 2018 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The identification of novel biomarkers is a crucial step in advancing towards earlier detection of diseases, as well as more personalized treatment options. This snapshot summarizes some of the biochemical and genomic biomarkers reported recently in the literature and at leading industry conferences in the field of neurological and psychiatric disorders. | ||
| 700 | 1 | |a Cole,US!aP. |e verfasserin |4 aut | |
| 700 | 1 | |a Dulsat,US!aC. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs of the future |d Barcelona : Prous Science - Thomson Reuters, 1976 |g 043(2018), 3, Seite 0193 |w (DE-627)13048489X |w (DE-600)752959-4 |w (DE-576)016071395 |x 0377-8282 |7 nnns |
| 773 | 1 | 8 | |g volume:043 |g year:2018 |g number:3 |g pages:0193 |
| 856 | 4 | 0 | |u https://doi.org/10.1358/dof.2018.043.03.2792546 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4125 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 043 |j 2018 |e 3 |h 0193 | ||